Development of udenafil-loaded microemulsions for intranasal delivery: In vitro and in vivo evaluations

Novel microemulsion system for the intranasal delivery of udenafil achieved rapid onset of action (Tmax = 1 min) and improved bioavailability (85.7%) compared to oral administration (6.6%) in rats.